Maravai Lifesciences Holdings's total assets for Q4 2025 were $770.58M, a decrease of -9.26% from the previous quarter. MRVI total liabilities were $397.87M for the fiscal quarter, a -4.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.